Renaissance Technologies (RenTech)'s ANIX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 61,173 shares of Anixa Biosciences, Inc. (ANIX) worth $157,826, representing 0.00% of the portfolio. First purchased in 2020-Q1, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in ANIX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2021, adding 124,499 shares. Largest reduction occurred in Q2 2022, reducing 138,773 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Anixa Biosciences (ANIX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Anixa Biosciences (ANIX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +7,300 | Add 13.55% | 61,173 | $2.58 |
| Q4 2025 | +11,109 | Add 25.98% | 53,873 | $3.12 |
| Q3 2025 | +15,091 | Add 54.53% | 42,764 | $3.30 |
| Q2 2025 | +6,200 | Add 28.87% | 27,673 | $3.30 |
| Q1 2025 | +6,900 | Add 47.35% | 21,473 | $2.86 |
| Q4 2024 | +3,900 | Add 36.54% | 14,573 | $2.32 |
| Q3 2024 | +10,673 | New Buy | 10,673 | $3.15 |
| Q2 2024 | -68,800 | Sold Out | 0 | $0.00 |
| Q1 2024 | +68,800 | New Buy | 68,800 | $3.12 |
| Q4 2023 | -10,000 | Sold Out | 0 | $0.00 |
| Q3 2023 | -49,300 | Reduce 83.14% | 10,000 | $3.30 |
| Q2 2023 | +37,998 | Add 178.38% | 59,300 | $0.00 |
| Q1 2023 | -26,598 | Reduce 55.53% | 21,302 | $0.01 |
| Q4 2022 | -9,300 | Reduce 16.26% | 47,900 | $0.00 |
| Q3 2022 | -28,682 | Reduce 33.40% | 57,200 | $4.91 |
| Q2 2022 | -138,773 | Reduce 61.77% | 85,882 | $3.06 |
| Q1 2022 | -106,145 | Reduce 32.09% | 224,655 | $2.74 |
| Q4 2021 | +118,600 | Add 55.89% | 330,800 | $2.97 |
| Q3 2021 | +87,701 | Add 70.44% | 212,200 | $4.77 |
| Q2 2021 | +124,499 | New Buy | 124,499 | $3.88 |
| Q2 2020 | -32,216 | Sold Out | 0 | $0.00 |
| Q1 2020 | +32,216 | New Buy | 32,216 | $1.58 |
Renaissance Technologies (RenTech)'s Anixa Biosciences Investment FAQs
Renaissance Technologies (RenTech) first purchased Anixa Biosciences, Inc. (ANIX) in Q1 2020, acquiring 32,216 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Anixa Biosciences, Inc. (ANIX) for 22 quarters since Q1 2020.
Renaissance Technologies (RenTech)'s largest addition to Anixa Biosciences, Inc. (ANIX) was in Q2 2021, adding 124,499 shares worth $483,000.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 61,173 shares of Anixa Biosciences, Inc. (ANIX), valued at approximately $157,826.
As of the Q1 2026 filing, Anixa Biosciences, Inc. (ANIX) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Anixa Biosciences, Inc. (ANIX) was 330,800 shares, as reported at the end of Q4 2021.